Your Body Mass Index (BMI) is often an indicator to diagnose obesity. Combating obesity is paramount to overall health. According to The National Health Institute, 1 in 3 adults are considered ...

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that the internationally recognised body mass index (BMI) cut-off points ...

Waist circumference is a stronger predictor of obesity-related cancer risk than BMI in men, but not in women, due to ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that the internationally recognized body mass index (BMI) cut-off points greatly ...

Waist-to-height ratio should be used in conjunction with BMI to assess overweight and obesity in children and adolescents, a researcher reported in a study published in Obesity and Endocrinology.

“These results clearly indicate that we cannot rely only on BMI without considering the content and distribution of body composition in people with obesity across the different age groups ...

“These results clearly indicate that we cannot rely only on BMI without considering the content and distribution of body composition in people with obesity across the different age groups ...

Findings showed patients on setmelanotide saw a mean BMI reduction of 16.5% from baseline ... for the treatment of acquired hypothalamic obesity. Setmelanotide, a melanocortin-4 receptor agonist ...

More than half of the setmelanotide group had a BMI reduction of at least 15% during the trial. A group of children and adults with hypothalamic obesity receiving setmelanotide for 1 year had ...

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.